MTOR and cholangiocarcinoma: In colorectal cancer and cholangiocarcinoma, TRIM59 was shown to promote proliferation, but this was thought to be through the PI3K/AKT or PI3K/AKT/mTOR signaling pathway, respectively [326,328].